Psoriasis at the site of healed herpes zoster: Wolf's isotopic response [2];Psoriasis tras herpes zóster: Respuesta isotópica de Wolf

Actas Dermo-Sifiliograficas

Volumn 98, Issue 8, 2007, Pages 576-578

  Allegue, F ^a   Fachal, C ^a   Romo, M ^a   Lopez Miragaya M I ^a   Perez S ^a  

^a HOSPITAL DO MEIXOEIRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; EPIDERMIS HYPERPLASIA; HERPES ZOSTER; HUMAN; LETTER; PSORIASIS; SKIN MANIFESTATION; TREATMENT OUTCOME;

EID: 35348986939     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S0001-7310(07)70139-4     Document Type: Letter

References (11)

1. Requena L, Kutzner H, Escalonilla P, Ortiz S, Schaller JS, Rohwedders A. Cutaneous reactions at sites of herpes zoster scars: an expanded spectrum. Br J Dermatol. 1998;138:161-8.
2. Wolf R, Brenner S, Ruocco V, Filioli FG. Isotopic response. Int J Dermatol. 1995;34:341-8.
3. Russel B. Psoriasis zosteriformis. Br J Dermatol. 1950;62:314-6.
4. Ito T, Furukawa F. Psoriasis guttate acuta triggered by varicella zoster virus infection. Eur J Dermatol. 2000;10:226-7.
5. Lee HW, Lee DK, Rhee DY, Chang SE, Choi JH, Moon KC, et al. Erythema annulare centrifugum following herpes zoster infection: Wolf 's isotopic response. Br J Dermatol. 2005;153:1241-3.
6. Benedict CA. Viruses and the TNF-related cytokines, an evolving battle. Cytokine Growth Factor Rev. 2003;14:349-57.
7. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptative immune response. Annu Rev Immunol. 2001;19:65-91.
8. Vossen MT, Gent MR, Weel JF, de Jong MD, van Lier RA, Kuijpers TW. Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus. J Infect Dis. 2004;190:72-82.
9. Nikkels AF, Sadzot-Delvaux C, Pierard GE. Absence of intercellular adhesion molecule 1 expression in varicella zoster virus-infected keratinocytes during herpes zoster: another immune evasion strategy? Am J Dermatopathol. 2004;26:27-32.
10. rd. Biology of tumor necrosis factor-alpha-implications for psoriasis. Exp Dermatol. 2004;13:193-222.
11. Wallis RS, Ehlers S. Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab. Semin Arthritis Rheum. 2005;34 Suppl 1: 34-8.